Johnson & Johnson (JNJ) Tops Q3 EPS by 10c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to Johnson & Johnson (JNJ) Tops Q3 EPS by 10c; Raises Outlook
October 19, 2017 6:55 AM EDT
Johnson & Johnson (NYSE: JNJ) declared a quarterly dividend of $0.84 per share, or $3.36 annualized.
The dividend will be payable on December 12, 2017, to stockholders of record on November 28, 2017, with an ex-dividend date of November 27, 2017.
The annual yield on the dividend is 2.4 percent.
For a... More
October 18, 2017 7:49 AM EDT
Morgan Stanley raised its price target on Johnson & Johnson (NYSE: JNJ) to $145.00 (from $140.00) while maintaining a Overweight rating.
...
More
October 18, 2017 7:30 AM EDT
Jefferies raised its price target on Johnson & Johnson (NYSE: JNJ) to $161.00 (from $160.00) while maintaining a Buy rating following beat and raise results.
Analyst Jeffrey Holford notes their revenue and adjusted EPS estimates remain well above consensus.
"The Pharma division remains under-modeled by... More
October 18, 2017 7:03 AM EDT
Leerink Partners raised its price target on Johnson & Johnson (NYSE: JNJ) to $165.00 (from $150.00) while maintaining a Outperform rating.
Analyst Danielle Antalffy said outperformance highlights momentum. 217/2018 outlook moves higher.
...
More
October 17, 2017 5:16 PM EDT
Stifel raised its price target on Johnson & Johnson (NYSE: JNJ) to $142.00 (from $140.00) while maintaining a Hold rating, following the company's third quarter earnings report.
Analyst Rick Wise notes a positive outlook, as the company reported third quarter earnings per share and revenue results above... More
